1-2 of 2
Jérome Jaubert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High Efficacy and Particular Safety Profile of Imatinib Mesylate (Glivec®) in Elderly Patients with CML in Chronic Phase: Results of the AFR04 Prospective Study.

Philippe Rousselot, Franck Nicolini, François Xavier Mahon, Delphine Réa, Jérome Jaubert, Christian Berthou, Josy Reiffers, Joelle Guilhot, François Guilhot
Journal: Blood
Blood (2007) 110 (11): 1039.
https://doi.org/10.1182/blood.V110.11.1039.1039
Published: 2007
Journal Articles

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy

Clinical Trials & Observations
Thierry Facon, Jean-Yves Mary, Brigitte Pégourie, Michel Attal, Marc Renaud, Alain Sadoun, Laurent Voillat, Véronique Dorvaux, Cyrille Hulin, Gérard Lepeu, Jean-Luc Harousseau, Jean-Paul Eschard, Augustin Ferrant, Michel Blanc, Frédéric Maloisel, Hubert Orfeuvre, Jean-François Rossi, Isabelle Azaïs, Mathieu Monconduit, Philippe Collet, Bruno Anglaret, Ibrahim Yakoub-Agha, Marc Wetterwald, Houchingue Eghbali, Marie-Christine Vekemans, Hervé Maisonneuve, Jacques Troncy, Bernard Grosbois, Chantal Doyen, Antoine Thyss, Jérome Jaubert, Philippe Casassus, Béatrice Thielemans, Régis Bataille, for the Intergroupe Francophone du Myélome (IFM) group
Journal: Blood
Blood (2006) 107 (4): 1292–1298.
https://doi.org/10.1182/blood-2005-04-1588
Published: 2006